3.17. Analysis.

Comparison 3: Hypoxia‐inducible factor (HIF) stabiliser versus erythropoiesis‐stimulating agent (ESA), Outcome 17: Cancer

Comparison 3: Hypoxia‐inducible factor (HIF) stabiliser versus erythropoiesis‐stimulating agent (ESA), Outcome 17: Cancer